CN104435682A - Traditional Chinese medicine for treating convalescent viral myocarditis - Google Patents
Traditional Chinese medicine for treating convalescent viral myocarditis Download PDFInfo
- Publication number
- CN104435682A CN104435682A CN201410677920.7A CN201410677920A CN104435682A CN 104435682 A CN104435682 A CN 104435682A CN 201410677920 A CN201410677920 A CN 201410677920A CN 104435682 A CN104435682 A CN 104435682A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- convalescent
- viral myocarditis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010047470 viral myocarditis Diseases 0.000 title claims abstract description 17
- 239000003814 drug Substances 0.000 title claims abstract description 12
- 239000010231 banlangen Substances 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims abstract description 3
- 241000756943 Codonopsis Species 0.000 claims description 8
- 210000001161 mammalian embryo Anatomy 0.000 claims description 6
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 abstract description 5
- 241000007126 Codonopsis pilosula Species 0.000 abstract description 3
- 240000002853 Nelumbo nucifera Species 0.000 abstract description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 241001145025 Saussurea involucrata Species 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 239000000047 product Substances 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 210000002216 heart Anatomy 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 206010033557 Palpitations Diseases 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 208000037920 primary disease Diseases 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 208000013220 shortness of breath Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241001278898 Glycyrrhiza inflata Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 229930010555 Inosine Natural products 0.000 description 2
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 244000248557 Ophiopogon japonicus Species 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229960003786 inosine Drugs 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 241000357628 Codonopsis pilosula subsp. tangshen Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 244000146486 Glehnia littoralis Species 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 241000334154 Isatis tinctoria Species 0.000 description 1
- 240000003271 Leonurus japonicus Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 241000209477 Nymphaeaceae Species 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 206010034944 Photokeratitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000133134 Saussurea Species 0.000 description 1
- 241001373816 Saussurea laniceps Species 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 241000011945 Sideritis eriocephala Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 235000006085 Vigna mungo var mungo Nutrition 0.000 description 1
- 240000005616 Vigna mungo var. mungo Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229940056319 ferrosoferric oxide Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 208000023482 precordial pain Diseases 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000008492 tangshen Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating convalescent viral myocarditis. The traditional Chinese medicine is prepared from the following raw medicinal materials in parts by weight: 10 parts of radix glehniae, 8 parts of codonopsis pilosula, 6 parts of saussurea involucrata, 8 parts of herba leonuri, 6 parts of lotus seed cores, 15 parts of magnetite, 9 parts of radix isatidis, 6 parts of radix ophiopogonis, and 3 parts of raw licorice. Proved by clinical experiments, the traditional Chinese medicine disclosed by the invention can safely and effectively treat the convalescent viral myocarditis.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to one and be used for the treatment of the convalescent Chinese medicine of viral myocarditis.
Background technology
Definition
Viral myocarditis convalescent period, precordial pain, felt oppressed in ambition, pale complexion, inability to breathe regularly due to shortness of breath, and weak grade is main clinical manifestation, relevant to traditional Chinese medical science various diseases usually with cardiopalmus.Though record without special in traditional Chinese medical science ancient medical book, there is the description with primary disease similar symptoms.As namely there being the description of " heart fright with palpitation like feeling of being arrested " in Huangdi's Internal Classics, and proposing this disease with abnormal weather, experiencing six climate exopathogens pathogenic factor closely related.
The cause of disease
Endogenous cause of ill: ferritic healthy energy virtual loss, exopathogenic factor: the evil invasion and attack of warm poison.The traditional Chinese medical science is thought, except exopathogen, deficiency of vital QI is that important or even main aspect occurs primary disease, i.e. being invaded by exogenous pathogen and falling ill again on weakened body resistance basis.Deficiency of vital QI or by innate deficiency, or because of overstrain, consumption is hindered caused by healthy energy.Have in Huangdi's Internal Classics " healthy energy deposit in, heresy can not be done ", " gathering of heresy, its gas must be empty ", discussions such as " BI-syndrome involved the blood vessels endlessly, feel exopathogen again, inside gives up in the heart ", all illustrate weakened body resistance body easily attack by pathogen, give up in evil poison and then can send out as primary disease in the heart.
Symptom
Pathologic through acute stage enters people's convalescent period, and the heresy of remaining pyretic toxicity continues to burn and damages battalion's the moon, can cause the impairment of both QI and YIN of the heart.The motive is impaired, and sun loses and rouses oneself, and gasification dereliction of duty, can cause palpitation with a distress feeling uneasiness.The heart-yin consumption wound, heart arteries and veins loses supports, and the moon sun not processed, can cause palpitation and uneasiness.Disease sees shortness of breath and palpitation, feeling of oppression and pain in the chest, and xerostomia is weak, the few tongue of red tongue, thready and rapid pulse.
Medical material present Research involved in the present invention is as follows:
Radix Glehniae: [source] this product is the dry root of samphire glehnia littoralis Glehnia littoralis Fr. Schmidt ex Miq..Summer, Qiu Erji excavate, and removing fibrous root, cleans, slightly dry in the air, and put after scalding in boiling water, and removing crust is dry.Or clean convection drying.[nature and flavor] sweet, micro-hardship, is slightly cold.[return through] attaches to the lung and stomach meridians.[function cures mainly] nourishing YIN and clearing away lung-heat, reinforcing stomach reg fluid.For lung-heat type cough, chronic cough expectorant blood, calentura Tianjin wound is thirsty.[usage and dosage] 4.5 ~ 9g.[attention] should not with Rhizoma et radix veratri (Radix Rhizoma Veratri) with using.
Radix Codonopsis: [source] this product is the dry root of Campanulaceae Radix Codonopsis Codonopsis pilosula (Franch.) Nannf., element flower Radix Codonopsis (RADIX CODONOPSIS PILOSULAE from Northwest of China) Codonopsis pilosula Nannf. var. modesta (Nannf.) L. T. Shen or radix codonpsis tangshen Codonopsis tangshen Oliv..Autumn excavates, and cleans, dries.[nature and flavor] are sweet, flat.[return through] returns spleen, lung meridian.[function cures mainly] invigorating the spleen and replenishing QI, spleen invigorating lung benefiting.For deficiency of the spleen and lung, cardiopalmus of breathing hard, anorexia and loose stool, dyspnea due to deficiency is coughed, and interior-heat is quenched one's thirst.[usage and dosage] 9 ~ 30g.[attention] should not with Rhizoma et radix veratri (Radix Rhizoma Veratri) with using.
Herba Saussureae Involueratae: [source] Compositae Genus Saussurea plant Saussurea laniceps Saussurea laniceps Hand.-Mazz. and Saussurea eriocephala S. eriocephala Franch, is used as medicine with whole herb with root.Summer gathers, and Herb pulls up, and trembles clean silt, dries.[nature and flavor] sweet, micro-hardship, temperature.[function cures mainly] kidney invigorating and YANG supporting, regulating menstruation, hemostasis.For snow blindness, toothache, rheumatic arthritis, sexual impotence, menoxenia, metrorrhagia, leucorrhea; Wound hemorrhage is controlled in external.[usage and dosage] 3 ~ 5 money; Suitable amount used externally, fresh herb mashes deposited affected part.
Herba Leonuri: [source] this product is the fresh or dry aerial parts of labiate Herba Leonuri Leonurus japonicus Houtt..Fresh goods Seedling Stage in spring is tapped to first summer flower early stage; Dry product stem and leaf in summer is luxuriant, Hua Weikai or tap when just opening, and dry, or cutting is dried.[nature and flavor] are bitter, pungent, are slightly cold.[return through] returns liver, pericardium channel.[function cures mainly] promoting blood flow to regulate menstruation, inducing diuresis to remove edema.For menoxenia, dysmenorrhea, amenorrhea, lochiorrhea, edema oliguria; Acute nephritis edema.[usage and dosage] 9 ~ 30g; Fresh goods 12 ~ 40g.[attention] anemia of pregnant woman is forbidden.
Embryo nelumbinis: [source] this product is the green radicle (Plumula Nelumbinis) in the middle of the mature seed of nymphaeaceae plant lotus Nelumbo nucifera Gaertn..Take out, dry.[nature and flavor] are bitter, cold.[return through] GUIXIN, kidney channel.[function cures mainly] clearing away heart-fire for tranquillization, restoring normal coordination between the heart and kidney, unsmoothing the sperm and stopping bleeding.For heat attacking the pericardium, unconsciousness and delirium, disarmony between the heart and kidney, insomnia seminal emission, heat in blood is spitted blood.[usage and dosage] 2 ~ 5g.
Magnetitum: [source] this product is oxide-based mineral spinelle race magnetic iron ore, main containing ferroso-ferric oxide (Fe3O4).After excavating, except roguing stone.[nature and flavor] are salty, cold.[return through] returns liver, the heart, kidney channel.[function cures mainly] suppressing the hyperactive liver and subsiding YANG, hearing-improing and eyesight improving, tranquillizing the mind by relieving convulsion, helping inspiration to relieve asthma.For having a dizzy spell, blurring of vision, Hiccough and deaf, palpitation with fear insomnia, asthma of suffering from a deficiency of the kidney.[usage and dosage] 9 ~ 30g, is decocted first.
Radix Isatidis: [source] this product is the dry root of cruciferae isatis Isatis indigotica Fort..Autumn excavates, and removing silt, dries.[nature and flavor] are bitter, cold.[return through] GUIXIN, stomach warp.[function cures mainly] heat-clearing and toxic substances removing, removing heat from blood sore-throat relieving.For maculae caused by violent heat pathogen, crimson tongue is purple dark, mumps, sore throat, scarlet fever, major part pestilence, erysipelas, carbuncle.[usage and dosage] 9 ~ 15g.
Radix Ophiopogonis: [source] this product is the dried root of liliaceous plant Radix Ophiopogonis (dwarf lilyturf) Ophiopogon japonicus (Thunb.) Ker-Gawl..Summer excavates, and cleans, is repeatedly exposed to the sun, banks up, to doing very likely, and removing fibrous root, dry.[nature and flavor] are sweet, and micro-hardship, is slightly cold.[return through] GUIXIN, lung, stomach warp.[function cures mainly] YIN nourishing and the production of body fluid promoting, lung moistening clears away heart-fire.For dryness of the lung dry cough.Chronic consumptive disease is coughed, and Tianjin wound is thirsty, vexed insomnia, and interior-heat is quenched one's thirst, dryness of the intestine constipation; Pharyngeal diphtheria.[usage and dosage] 6 ~ 12g.
Radix Glycyrrhizae: [source] this product is the dry root of glycyrrhizic legume Glycyrrhiza uralensis Fisch., Glycyrrhiza inflata Bat. Glycyrrhiza inflata Bat. or Glycyrrhiza glabra L. Glycyrrhiza glabra L..Spring, Qiu Erji excavate, and removing fibrous root, dries.Nature and flavor] sweet, flat.[return through] GUIXIN, lung, spleen, stomach warp.[function cures mainly] invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.For weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, the anxious pain of gastral cavity abdomen, extremity contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.[usage and dosage] 1.5 ~ 9g.[attention] should not with Radix Euphorbiae Pekinensis, Flos Genkwa, Radix Kansui with using.
Summary of the invention
The present invention aims to provide one and is used for the treatment of the convalescent Chinese medicine of viral myocarditis, by selecting suitable medical material and proportioning thereof, reaches the safe and effective object being applied to viral myocarditis convalescent care.
In order to achieve the above object, the present invention is by the following technical solutions:
One is used for the treatment of the convalescent Chinese medicine of viral myocarditis, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Radix Glehniae 10 parts, Radix Codonopsis 8 parts, Herba Saussureae Involueratae 6 parts, Herba Leonuri 8 parts, embryo nelumbinis 6 parts, Magnetitum 15 parts, Radix Isatidis 9 parts, Radix Ophiopogonis 6 parts, Radix Glycyrrhizae 3 parts.
Inventor thinks that the viral myocarditis cause of disease is positive QI-insufficiency, and the heart invaded in an opponent's defence by warm evil poison is primary disease morbidity main cause, and blood stasis, expectorant are turbid be pathological product in pathological process, and consumption impairment of QI is cloudy, and blood vessels retardance is main pathological change; Viral myocarditis convalescent period pathogenesis is deficiency of both QI and YIN, and residual poison is most, therefore assembly is our.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, physical data
Outpatient service is collected and viral myocarditis reconvalescent 254 example of being in hospital altogether in inventor in July, 2010 ~ 2013 between year March, be divided into treatment group 127 example and matched group 127 example at random, treatment group man 67 example, female 60 example, 15.5 ~ 50.6 years old age, 22.5 years old mean age, the course of disease 1 ~ 3 year; Matched group man 69 example, female 58 example, 15.1 ~ 48.8 years old age, 21.3 years old mean age, the course of disease 1 ~ 3 year.2 groups of sexes, age and course of disease comparing difference not statistically significants, have comparability.
2, test method
2.1 Therapeutic Method
The decoct that the oral the present invention for the treatment of group obtains according to specific embodiment 1, every day 3 times.4 weeks courses for the treatment of.
Matched group oral vitamin C, inosine (VITAMIN C TABLET by Tag pharmaceutcal corporation, Ltd of Heilongjiang Province produce, lot number: 20030504, every sheet 0.05g, every bag of 0.1g; Inosine tablets is produced by Shanghai modern Ha Sen pharmaceutcal corporation, Ltd, lot number: 05090302, every sheet 0.1, and every bag of 0.1g takes according to its description).4 weeks courses for the treatment of.
3, therapeutic outcome
Diagnostic criteria
Cure: clinical symptoms, sign disappear, the every inspection of the laboratorys such as electrocardiogram myocardium enzyme recovers normal;
Effective: the every inspections of laboratory such as clinical symptoms, sign disappear substantially, electrocardiogram myocardium enzyme recover normal substantially:
Effective: the every inspections of laboratory such as clinical symptoms, sign make moderate progress, electrocardiogram myocardium enzyme have certain improvement:
Invalid: clinical symptoms, sign and lab testing are all without improvement.
Therapeutic outcome is in table 1.
Table 1 liang group comparitive study
| Group | n | Cure | Effective | Effectively | Invalid | Total effective rate (%) | Serious adverse reaction example |
| Treatment group | 127 | 61 | 34 | 27 | 5 | 96.1% | 0 |
| Matched group | 127 | 31 | 43 | 22 | 31 | 75.6% | 0 |
Compare with matched group,
*p<0.05.
Visible, the medicine that the present invention obtains can safe and effective treatment viral myocarditis convalescent period, has promotional value.
Detailed description of the invention
In order to understand better and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Specific embodiment 1
Take: Radix Glehniae 10 grams, Radix Codonopsis 8 parts, Herba Saussureae Involueratae 6 grams, Herba Leonuri 8 grams, embryo nelumbinis 6 grams, Magnetitum 15 grams, Radix Isatidis 9 grams, Radix Ophiopogonis 6 grams, Radix Glycyrrhizae 3 grams; First Magnetitum is added 6 times of water gagings, decoct 1 hour, filter; Filtering residue and all the other 8 herbal medicines add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 grams, must meet the decoct of adult normal's one day consumption.
Be used for the treatment of viral myocarditis convalescent period.Oral, every bu morning, noon and afternoon take for three times.
Specific embodiment 2
Take: Radix Glehniae 10 grams, Radix Codonopsis 8 parts, Herba Saussureae Involueratae 6 grams, Herba Leonuri 8 grams, embryo nelumbinis 6 grams, Magnetitum 15 grams, Radix Isatidis 9 grams, Radix Ophiopogonis 6 grams, Radix Glycyrrhizae 3 grams; First Magnetitum is added 6 times of water gagings, decoct 1 hour, filter; Filtering residue and all the other 8 herbal medicines add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, must meet the powder of adult normal's one day consumption.
Be used for the treatment of viral myocarditis convalescent period.Oral, daily once.
Specific embodiment 3
Take: Radix Glehniae 10 grams, Radix Codonopsis 8 parts, Herba Saussureae Involueratae 6 grams, Herba Leonuri 8 grams, embryo nelumbinis 6 grams, Magnetitum 15 grams, Radix Isatidis 9 grams, Radix Ophiopogonis 6 grams, Radix Glycyrrhizae 3 grams; First Magnetitum is added 6 times of water gagings, decoct 1 hour, filter; Filtering residue and all the other 8 herbal medicines add 6 times of water gagings, decoct 3 times, and each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, must meet the capsule of adult normal's one day consumption.
Be used for the treatment of viral myocarditis convalescent period.Oral, every bu is taken for twice sooner or later.
Claims (1)
1. one kind is used for the treatment of the convalescent Chinese medicine of viral myocarditis, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Radix Glehniae 10 parts, Radix Codonopsis 8 parts, Herba Saussureae Involueratae 6 parts, Herba Leonuri 8 parts, embryo nelumbinis 6 parts, Magnetitum 15 parts, Radix Isatidis 9 parts, Radix Ophiopogonis 6 parts, Radix Glycyrrhizae 3 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410677920.7A CN104435682A (en) | 2014-11-24 | 2014-11-24 | Traditional Chinese medicine for treating convalescent viral myocarditis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410677920.7A CN104435682A (en) | 2014-11-24 | 2014-11-24 | Traditional Chinese medicine for treating convalescent viral myocarditis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104435682A true CN104435682A (en) | 2015-03-25 |
Family
ID=52882943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410677920.7A Pending CN104435682A (en) | 2014-11-24 | 2014-11-24 | Traditional Chinese medicine for treating convalescent viral myocarditis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104435682A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1172656A (en) * | 1996-08-02 | 1998-02-11 | 何众 | Medicine for treating asthenia-syndrome type viral myocarditis coused by enterovirus |
| US20080167372A1 (en) * | 2005-07-22 | 2008-07-10 | The Hong Kong University Of Science And Technology | Schisandrin b preparation |
| CN101637563A (en) * | 2008-08-01 | 2010-02-03 | 上海慈济药业有限公司 | A Chinese medicinal composition for treating viral myocarditis, and its preparation method |
-
2014
- 2014-11-24 CN CN201410677920.7A patent/CN104435682A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1172656A (en) * | 1996-08-02 | 1998-02-11 | 何众 | Medicine for treating asthenia-syndrome type viral myocarditis coused by enterovirus |
| US20080167372A1 (en) * | 2005-07-22 | 2008-07-10 | The Hong Kong University Of Science And Technology | Schisandrin b preparation |
| CN101637563A (en) * | 2008-08-01 | 2010-02-03 | 上海慈济药业有限公司 | A Chinese medicinal composition for treating viral myocarditis, and its preparation method |
Non-Patent Citations (4)
| Title |
|---|
| 杨爱东: "《温病学传承与现代研究》", 31 January 2013, 上海科学技术出版社 * |
| 郑克勤: "益气养阴活血法治病毒性心肌炎48例体会", 《江西中医药》 * |
| 金银生等: "中西医结合分期治疗急性病毒性心肌炎31例", 《实用中西医结合临床》 * |
| 陈凯等: "中西医结合治疗病毒性心肌炎62例", 《时珍国医国药》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104547525A (en) | Drug composition for NSCLC (Non Small Cell Lung Cancer) prevention and preparation method thereof | |
| CN102000164B (en) | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof | |
| CN103550696A (en) | Medicine for treating lung cancer | |
| CN102631647A (en) | Chinese patent medicine mixture for treating acute urticaria | |
| CN102600426B (en) | Chinese medicinal preparation for promoting blood circulation to remove blood stasis and preparation method thereof | |
| CN103055285A (en) | Traditional Chinese medicine for treating forepart hepetocirrhosis and preparation method thereof | |
| CN104800382A (en) | Traditional Chinese medicine composition for treating colds, as well as preparation method and application thereof | |
| CN103341124B (en) | Traditional Chinese medicine for treating cardiac neurosis | |
| CN104225399A (en) | Traditional Chinese medicine for treating pulmonary tuberculosis | |
| CN104688885A (en) | Traditional Chinese medicine for treating acute cholecystitis | |
| CN104771578A (en) | Traditional Chinese medicine for treating allergic rhinitis | |
| CN103520697A (en) | Traditional Chinese medicine for treating qi-yin deficiency syndrome type chest stuffiness and pains | |
| CN103520673B (en) | Traditional Chinese medicine for treating deficiency of Qi and blood syndrome type of menopathy | |
| CN102641424B (en) | Chinese prepared medicine mixture for treating acute urticaria | |
| CN104435682A (en) | Traditional Chinese medicine for treating convalescent viral myocarditis | |
| CN105617146A (en) | Traditional Chinese medicine composition for preventing and treating infantile recurrent respiratory tract infection and preparation method thereof | |
| CN103948856A (en) | Traditional Chinese medicament for treating artories and veims stasis syndrome chest stuffiness and pains | |
| CN105056046A (en) | Traditional Chinese medicine oral liquid for treating cold and cough and preparation method thereof | |
| CN104027760A (en) | Traditional Chinese medicament for treating wind-phlegm in lung type asthma | |
| CN102631648A (en) | Chinese patent medicine for treating acute urticaria | |
| CN104491528A (en) | Traditional Chinese medicine for treating spontaneous perspiration | |
| CN102920855B (en) | Traditional Chinese medicine for treating cancers | |
| CN105521478A (en) | Traditional Chinese medicinal composition for treating insomnia with palpitation | |
| CN105561101A (en) | Traditional Chinese medicine preparation for treating phthisis and preparation method thereof | |
| CN105106405A (en) | Traditional Chinese medicine for treating allergic eczema |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150325 |